Results 81 to 90 of about 4,519 (191)

Impaired Mesopic Visual Acuity in Eyes with Early Age-Related Macular Degeneration [PDF]

, 2012
Purpose.: To determine photopic and mesopic distance high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD).
Barrio de Santos, Ana Rosa, Clement-Corral, Amaya, Gomez-Sanz, Fernando J, Palomo Álvarez, Catalina, Perez Carrasco, Maria Jesus, Puell Marín, María Cinta   +5 more
core   +2 more sources

Automatic Classification of Bright Retinal Lesions via Deep Network Features

, 2017
The diabetic retinopathy is timely diagonalized through color eye fundus images by experienced ophthalmologists, in order to recognize potential retinal features and identify early-blindness cases.
Elawady, Mohamed, Sadek, Ibrahim, Shabayek, Abd El Rahman   +2 more
core  

Role of advanced technology in the detection of sight-threatening eye disease in a UK community setting. [PDF]

, 2019
Background/aims: To determine the performance of combinations of structural and functional screening tests in detecting sight-threatening eye disease in a cohort of elderly subjects recruited from primary care.
Ctori, I., Dabasia, P., Edgar, D. F., Fidalgo, B. R., Jindal, A., Lawrenson, J., Peto, T.   +6 more
core   +1 more source

Clinical disorders affecting mesopic vision [PDF]

, 2006
Vision in the mesopic range is affected by a number of inherited and acquired clinical disorders. We review these conditions and summarize the historical background, describing the clinical characteristics alongside the genetic basis and molecular ...
Abramowicz M., Ahmed F., Ahmed F., Al-Kubaisy W., Asrat Y., Ayyagari R., Baillie I., Bergen H. R., Berson E., Bloem M., Bordley J., Bret-Dibat C., Brink E., Burstedt M., Burstedt M., Capon M., Carr R., Carr R., Chisholm C., Christian P., Cunier F., de Pee S., DOG, Donnen P., Duke-Elder S., Fishman G., Fuchs A., Fuchs A., Gross-Jendroska M., Guy J., Haidar J., Hartmann E., Hayashi T., Hayashi T., Heckenlively J., Kalloniatis M., Kamei M., Kellner U., Kolling G., Lauber H., Lei B., Lorenz B., Main A., Marmor M., Marmor M., McBain V., Mele L., Milam A., Miyake Y., Miyake Y., Miyake Y., Mizuo A., Morimura H., Nabakwe E., Nettleship E., Oguchi C., Onder C., Parker W., Perlman I., Pesudovs K., Phelan J., Polans A., Polkinghorne P., Ramalho R., Reiner J., Resnikoff S., Ripps H., Rosen D., Rosen D., Rougier M., Ruiz-Martin M., Saunders C., Sawyer R., Schaumberg D., Schemann J., Schlote T., Schubert G., Sharp D., Shaw C., Skinner H., Smith R. A. J., Sommer A., Somner A., Sorsby A., Souied E., Spalton D., Stephenson S., Stockman A., Tabata Y., Takeuchi T., Taren D., Thirkill C., Tielsch J., Underwood B., Uyemura M., Weinstein J., Weiss J., Weiss N., Wolf G., Wolf G., Wolfe J. E.   +100 more
core   +1 more source

Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease. [PDF]

, 2014
The key to reducing the individual and societal burden of age-related macular degeneration (AMD)-related vision loss, is to be able to initiate therapies that slow or halt the progression at a point that will yield the maximum benefit while minimizing ...
Baron, Robert V, Conley, Yvette P, Gorin, Michael B, Nusinowitz, Steven, Ortube, Maria C, Weeks, Daniel E   +5 more
core   +3 more sources

Assessment of early and late dry age-related macular degeneration with spectral-domain optical coherence tomography and fundus autofluorescence

IJRETINA (International Journal of Retina)
Aim: To assess features of early and late dry age-related macular degeneration (ARMD) using spectral-domain optical coherence tomography (SDOCT) versus fundus Autofluorescence (FAF). Method: Observational cross-sectional study conducted from January-2022
Archana Singh, Mohini Agrawal, Harikrishnan Vannadil, Sunandan Bhatta   +3 more
doaj   +1 more source

Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment

EBioMedicine, 2016
Importance: Age-related macular degeneration (AMD) remains the leading cause of blindness in developed countries, and affects more than 150 million worldwide.
Demetrios G. Vavvas, Anthony B. Daniels, Zoi G. Kapsala, Jeremy W. Goldfarb, Emmanuel Ganotakis, John I. Loewenstein, Lucy H. Young, Evangelos S. Gragoudas, Dean Eliott, Ivana K. Kim, Miltiadis K. Tsilimbaris, Joan W. Miller   +11 more
doaj   +1 more source

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation

American Journal of Ophthalmology Case Reports, 2020
Purpose: To describe the long-term follow-up of a patient with perifoveal exudative vascular anomalous complex (PEVAC) treated initially with intravitreal injections of anti-vascular endothelial growth factor (VEGF) followed by focal thermal laser ...
Federico Corvi, Giulia Corradetti, Alexander Juhn, SriniVas Sadda   +3 more
doaj   +1 more source

Developing an image-based grading scale for peripheral drusen to investigate associations of peripheral drusen type with age-related macular degeneration

Scientific Reports
Age-related macular degeneration (AMD) is a leading cause of blindness. It is associated with peripheral drusen which has not been categorized. We investigated peripheral drusen to validate an image grading system and to understand possible associations ...
Paripoorna Sharma, Fritz Gerald P. Kalaw, Andrew Lin, Evan H. Walker, Shyamanga Borooah   +4 more
doaj   +1 more source

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration [PDF]

, 2017
Background: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption.
Age-Related Eye Disease Study 2 Research Group, Age-Related Eye Disease Study Research Group, Age-Related Eye Disease Study Research Group, Akuffo, Akuffo, Andreatta, Angelo, Anonymous, Arnold, Bahrami, Barakat, Bartlett, Bartlett, Beatty, Beatty, Benzie, Berrow, Bjelakovic, Bonds, Bone, Broadhead, Bunce, Buschini, Cangemi, Carneiro, Chew, Chew, Chew, Chew, Chew, Chew, Christen, Christen, Christen, Christen, Clemons, Connolly, Cumurcu, Dawczynski, Dawczynski, Downie, Early Treatment Diabetic Retinopathy Study Research Group, Evans, Evans, Evans, Falsini, Franciose, Garrett, Garrett, Glanville, Goodrow, Grover, Hanus, Holz, Huang, Huang, Huang, Huang, Hubbard, Johnson, Kaiser, Kamburoglu, Khachik, Klein, Kolber, Kopsell, Kvansakul, Lai, Landrum, Lim, Liu, Lonn, Ma, Ma, Manikandan, Meagher, Moeller, Moriarty-Craige, Murray, Neelam, Newsome, Newsome, Nolan, Nolan, Nolan, Nussenblatt, Omenn, Owsley, Piermarocchi, Prasad, Richer, Richer, Richer, Richer, Robman, Rodriguez-Carmona, Rosenthal, Rudnicka, Sabour-Pickett, Sacconi, Sasamoto, Scalinci, Schalch, Schmetterer, Schmidl, Scorolli, Souied, Stur, Taylor, The, The Age-Related Eye Disease Study 2 (AREDS2) Research Group, The Age-Related Eye Disease Study Research Group, Tian, Tikellis, Told, Told, Trieschmann, Vannas, Wang, Wang, Weigert, Wenzel, Wolf-Schnurrbusch, Wong, Zampatti, Zeimer, Zhao   +126 more
core   +3 more sources